AGP Executive Report
Last update: 5 hours agoDutch Water Diplomacy: Japan’s Emperor Naruhito toured a major Dutch hydraulic research facility, focusing on flood-control work and artificial wave testing. Regulatory Shock in Biotech: Netherlands-based uniQure says the FDA will accept its Huntington’s gene therapy data for a submission, with a filing expected July–September—another sign of shifting rare-disease review flexibility. AI & Chips Tensions: Reports claim Tesla “cooked” Full Self-Driving safety numbers used for approvals in Sweden and the Netherlands, while broader US–China chip friction shows no easy reset. Dutch Health & Research: Peripheral nerve specialists gathered in Maastricht for new imaging advances, including MR neurography comparisons across disorders. Cancer Research Governance: National Cancer Center added two prominent oncology researchers to its Scientific Advisory Board. Netherlands in Global Security Tech: Ukraine’s defence minister credited Dutch support for Patriot air defence and unmanned technology. Mobility & Infrastructure Tech: ProRail and partners launched BIM for Rail Bootcamp 2026 in Riga, tied to Rail Baltica’s digital delivery push. Space/Materials Innovation: CuspAI is reportedly raising a $400M round to speed up material discovery for hardware R&D.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![EU drug pricing: Belgium backs coordination push as Greece urges biotech scale-up [Advocacy Lab]](https://www.euractiv.com/content/uploads/sites/2/2026/06/a493f53b-cda5-4ecf-a6fc-a3b3242d20c7.jpg)
